Drugs News and Research

RSS

pSivida reports that Alimera Sciences gets FDA Complete Response Letter for ILUVIEN NDA

pSivida Corp., a specialty pharmaceutical company that is a leader in developing sustained release drugs for treatment of back-of-the-eye diseases, today announced that its licensee Alimera Sciences, Inc. has received a Complete Response Letter for the New Drug Application for ILUVIEN from the U.S. Food and Drug Administration.

18 Oct 2013

Anacor Pharmaceuticals appoints arbitrator to resolve its dispute with Valeant Pharmaceuticals

Anacor Pharmaceuticals (NASDAQ:ANAC) today announced that the arbitrator appointed to resolve its dispute with Valeant Pharmaceuticals, Inc. (Valeant), successor in interest to Dow Pharmaceutical Sciences, Inc. (DPS), has issued an Interim Final Award in favor of Anacor, awarding Anacor $100 million in damages as well as all costs of the arbitration and reasonable attorney's fees.

18 Oct 2013

Two drugs in combination improve survival in patients with advanced pancreatic cancer

Investigators at the Vall d´Hebron University Hospital and the Vall d'Hebron Institute of Oncology (VHIO), have participated in an international phase III study, published in The New England Journal of Medicine.

18 Oct 2013

Researchers identify C. perfringens type B bacteria believed to trigger multiple sclerosis

A research team from Weill Cornell Medical College and The Rockefeller University has identified a bacterium it believes may trigger multiple sclerosis, a chronic, debilitating disorder that damages myelin forming cells in the brain and spinal cord.

18 Oct 2013

State exchanges wrestle with provider directories, search tools

News outlets report on some of the challenges and sign-up tallies for state-based online insurance marketplaces in California, Minnesota, Washington and Maryland. Also in the news, progress updates regarding outreach efforts and small businesses that are attempting to use the exchanges.

18 Oct 2013

Study: Sleep allows brain to flush out damaging molecules linked with neurodegeneration

A good night's rest may literally clear the mind. Using mice, researchers showed for the first time that the space between brain cells may increase during sleep, allowing the brain to flush out toxins that build up during waking hours.

18 Oct 2013

Hospitals try new tactics to reduce hospital falls

The nation's medical workforce grapples with preventing falls in the hospital to improve patient safety. In the meantime, seniors in some places of the country are more likely to fill prescriptions for high-risk drugs, and Miami's seniors lead the nation in filling Medicare prescriptions.

18 Oct 2013

Quality of care provided by female doctors is higher than their male counterparts

According to a University of Montreal research team, the quality of care provided by female doctors is higher than that of their male counterparts while the productivity of males is greater.

18 Oct 2013

Use of effective, risky drug therapies by Medicare patients varies across US

A new report from the Dartmouth Atlas Project shows that the use of both effective and risky drug therapies by Medicare patients varies widely across U.S. regions, offering further evidence that location is a key determinant in the quality and cost of the medical care that patients receive.

18 Oct 2013

Combination of heat, doxorubicin drug and nanotech system may improve ovarian cancer treatment

The combination of heat, chemotherapeutic drugs and an innovative delivery system based on nanotechnology may significantly improve the treatment of ovarian cancer while reducing side effects from toxic drugs, researchers at Oregon State University report in a new study.

18 Oct 2013

Atorvastatin drug plus zoledronic acid may help treat toxoplasmosis

Researchers at the University of Georgia have discovered that a combination of two commonly prescribed drugs used to treat high cholesterol and osteoporosis may serve as the foundation of a new treatment for toxoplasmosis, a parasitic infection caused by the protozoan Toxoplasma gondii. They published their findings recently in PLOS Pathogens.

18 Oct 2013

Jain Foundation Steps Up Efforts To Find Cure For Muscular Dystrophy

...

17 Oct 2013

First Edition: October 17, 2013

Today's headlines include reports and analyses of the Capitol Hill deal to raise the debt limit and reopen the federal government, as well as the latest developments regarding the health law's federal and state health insurance exchanges.

17 Oct 2013

Severe allergies in young people: an interview with Lynne Regent, CEO of Anaphylaxis Campaign

Around one third of the UK population – approximately 19 million people – will develop an allergy at some time in their lives. A significant proportion of these – around a million people – suffer severe symptoms.

17 Oct 2013

Merck to present pharmacokinetic data on once-daily ISENTRESS at EACS

Merck, known as MSD outside the United States and Canada, is presenting pharmacokinetic data this week on investigational formulations of a once daily dose of ISENTRESS at the 14th European AIDS Conference, sponsored by the European AIDS Clinical Society.

17 Oct 2013

Proteins in CSF predict cognitive impairment before onset of disease

Johns Hopkins researchers say that by measuring levels of certain proteins in cerebrospinal fluid (CSF), they can predict when people will develop the cognitive impairment associated with Alzheimer's disease years before the first symptoms of memory loss appear.

17 Oct 2013

State highlights: Calif. Gov. Vetoes 'biosimilars' bill; health data gateway opens in Calif.; L.A. health workers required to get flu shots

A selection of health policy stories from California. A bill that would have allowed "biosimilar" drugs to be substituted for biologic drugs was vetoed over the weekend by Gov. Jerry Brown (D), who said it was premature to pass the law until the Federal Drug Administration has worked out standards for the new drugs.

17 Oct 2013

Where seniors live affects their health care and the medications they get

The Associated Press examines how geography can make a key difference in the treatments that Medicare beneficiaries receive. Other outlets look at the annual open enrollment period for Medicare prescription drug plans. USA Today reports that thousands who rely on nursing home trust funds have had their savings mismanaged or stolen.

17 Oct 2013

Researchers find novel drug target for anaplastic thyroid carcinomas

Anaplastic thyroid carcinomas are aggressive tumors that do not respond to traditional radio- or chemotherapeutic agents, and there currently is no cure or effective treatment available. Median survival from diagnosis is 5 months, and although ATC accounts for only 1.7% of all thyroid cancers in the U.S., it is responsible for a large proportion of thyroid cancer-related deaths.

17 Oct 2013

Scientists uncover faulty brain mechanism that may underlie schizophrenia in humans

Working with mice genetically engineered to display symptoms of schizophrenia, neuroscientists at the RIKEN-MIT Center for Neural Circuit Genetics at the Picower Institute for Learning and Memory at MIT have uncovered a faulty brain mechanism that may underlie schizophrenia and other psychiatric disorders in humans.

17 Oct 2013

Drugs News and Research

pSivida reports that Alimera Sciences gets FDA Complete Response Letter for ILUVIEN NDA

Anacor Pharmaceuticals appoints arbitrator to resolve its dispute with Valeant Pharmaceuticals

Two drugs in combination improve survival in patients with advanced pancreatic cancer

Researchers identify C. perfringens type B bacteria believed to trigger multiple sclerosis

State exchanges wrestle with provider directories, search tools

Study: Sleep allows brain to flush out damaging molecules linked with neurodegeneration

Hospitals try new tactics to reduce hospital falls

Quality of care provided by female doctors is higher than their male counterparts

Use of effective, risky drug therapies by Medicare patients varies across US

Combination of heat, doxorubicin drug and nanotech system may improve ovarian cancer treatment

Atorvastatin drug plus zoledronic acid may help treat toxoplasmosis

Jain Foundation Steps Up Efforts To Find Cure For Muscular Dystrophy

First Edition: October 17, 2013

Severe allergies in young people: an interview with Lynne Regent, CEO of Anaphylaxis Campaign

Merck to present pharmacokinetic data on once-daily ISENTRESS at EACS

Proteins in CSF predict cognitive impairment before onset of disease

State highlights: Calif. Gov. Vetoes 'biosimilars' bill; health data gateway opens in Calif.; L.A. health workers required to get flu shots

Where seniors live affects their health care and the medications they get

Researchers find novel drug target for anaplastic thyroid carcinomas

Scientists uncover faulty brain mechanism that may underlie schizophrenia in humans

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News